Michael Bonner is a Senior Scientist at AstraZeneca in the Cell Therapy Department, specializing in immune cell engineering. Currently, they are completing a PhD in Biochemistry at Karolinska Institutet, focusing on preclinical pharmacological inhibitors and genetic edits related to REDOX biology. Michael has over a decade of experience as a lab manager and research scientist, contributing more than 35 peer-reviewed publications and securing approximately $152,000 in research funding. Their expertise includes financial management, science communication, and a wide range of immunological assays, as well as mentoring the next generation of scientists.
This person is not in the org chart
This person is not in any teams
This person is not in any offices